Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
Taiwan Semiconductor
TSM
ASML Holding
ASML
US Stock MarketDetailed Quotes
HUMA Humacyte
- 1.960
- -0.050-2.49%
Close Mar 28 16:00 ET
- 1.930
- -0.030-1.53%
Post 19:56 ET
252.19MMarket Cap-1.46P/E (TTM)
2.130High1.760Low11.97MVolume2.120Open2.010Pre Close22.53MTurnover12.52%Turnover RatioLossP/E (Static)128.67MShares9.97052wk High-3.96P/B187.39MFloat Cap1.76052wk Low--Dividend TTM95.61MShs Float17.450Historical High--Div YieldTTM18.41%Amplitude1.760Historical Low1.881Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Humacyte Stock Forum
Humacyte Q4 Earnings: 34 Hospitals Eye New FDA-Approved Vascular Treatment
Investing.com -- Dr. Laura Niklason, President and CEO of Humacyte, Inc. (NASDAQ:HUMA), responded to a New York Times (NYSE:NYT) article that questioned the FDA’s approval of Symvess for commercial sales earlier this week. Niklason had previously withheld comment due to the company b...
No comment yet